Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 255

1.

TSPO polymorphism in individuals with alcohol use disorder: Association with cholesterol levels and withdrawal severity.

Wiers CE, Martins De Carvalho L, Hodgkinson CA, Schwandt M, Kim SW, Diazgranados N, Wang GJ, Goldman D, Volkow ND.

Addict Biol. 2019 Nov 12:e12838. doi: 10.1111/adb.12838. [Epub ahead of print]

PMID:
31713961
2.

Induced cardiomyocyte maturation: Cardiac transcription factors are necessary but not sufficient.

Dal-Pra S, Hodgkinson CP, Dzau VJ.

PLoS One. 2019 Oct 17;14(10):e0223842. doi: 10.1371/journal.pone.0223842. eCollection 2019.

3.

Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2.

Luo A, Jung J, Longley M, Rosoff DB, Charlet K, Muench C, Lee J, Hodgkinson CA, Goldman D, Horvath S, Kaminsky ZA, Lohoff FW.

Neuropsychopharmacology. 2019 Aug 29. doi: 10.1038/s41386-019-0500-y. [Epub ahead of print]

PMID:
31466081
4.

Relations between catechol-O-methyltransferase Val158Met genotype and inhibitory control development in childhood.

Bowers ME, Buzzell GA, Salo V, Troller-Renfree SV, Hodgkinson CA, Goldman D, Gorodetsky E, Martin McDermott J, Henderson HA, Fox NA.

Dev Psychobiol. 2019 Aug 1. doi: 10.1002/dev.21901. [Epub ahead of print]

PMID:
31372986
5.

OPRM1 rs1799971, COMT rs4680, and FAAH rs324420 genes interact with placebo procedures to induce hypoalgesia.

Colloca L, Wang Y, Martinez PE, Chang YC, Ryan KA, Hodgkinson C, Goldman D, Dorsey SG.

Pain. 2019 Aug;160(8):1824-1834. doi: 10.1097/j.pain.0000000000001578.

PMID:
31335650
6.

Working memory reflects vulnerability to early life adversity as a risk factor for substance use disorder in the FKBP5 cortisol cochaperone polymorphism, rs9296158.

Lovallo WR, Acheson A, Cohoon AJ, Sorocco KH, Vincent AS, Hodgkinson CA, Goldman D.

PLoS One. 2019 Jun 11;14(6):e0218212. doi: 10.1371/journal.pone.0218212. eCollection 2019.

7.

Exploratory locomotion, a predictor of addiction vulnerability, is oligogenic in rats selected for this phenotype.

Zhou Z, Blandino P, Yuan Q, Shen PH, Hodgkinson CA, Virkkunen M, Watson SJ, Akil H, Goldman D.

Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):13107-13115. doi: 10.1073/pnas.1820410116. Epub 2019 Jun 10.

8.

Early-Life Adversity and Blunted Stress Reactivity as Predictors of Alcohol and Drug use in Persons With COMT (rs4680) Val158Met Genotypes.

Lovallo WR, Cohoon AJ, Sorocco KH, Vincent AS, Acheson A, Hodgkinson CA, Goldman D.

Alcohol Clin Exp Res. 2019 Jul;43(7):1519-1527. doi: 10.1111/acer.14079. Epub 2019 May 31.

PMID:
31150143
9.

Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders.

Walters RK, Polimanti R, Johnson EC, McClintick JN, Adams MJ, Adkins AE, Aliev F, Bacanu SA, Batzler A, Bertelsen S, Biernacka JM, Bigdeli TB, Chen LS, Clarke TK, Chou YL, Degenhardt F, Docherty AR, Edwards AC, Fontanillas P, Foo JC, Fox L, Frank J, Giegling I, Gordon S, Hack LM, Hartmann AM, Hartz SM, Heilmann-Heimbach S, Herms S, Hodgkinson C, Hoffmann P, Jan Hottenga J, Kennedy MA, Alanne-Kinnunen M, Konte B, Lahti J, Lahti-Pulkkinen M, Lai D, Ligthart L, Loukola A, Maher BS, Mbarek H, McIntosh AM, McQueen MB, Meyers JL, Milaneschi Y, Palviainen T, Pearson JF, Peterson RE, Ripatti S, Ryu E, Saccone NL, Salvatore JE, Sanchez-Roige S, Schwandt M, Sherva R, Streit F, Strohmaier J, Thomas N, Wang JC, Webb BT, Wedow R, Wetherill L, Wills AG; 23andMe Research Team, Boardman JD, Chen D, Choi DS, Copeland WE, Culverhouse RC, Dahmen N, Degenhardt L, Domingue BW, Elson SL, Frye MA, Gäbel W, Hayward C, Ising M, Keyes M, Kiefer F, Kramer J, Kuperman S, Lucae S, Lynskey MT, Maier W, Mann K, Männistö S, Müller-Myhsok B, Murray AD, Nurnberger JI, Palotie A, Preuss U, Räikkönen K, Reynolds MD, Ridinger M, Scherbaum N, Schuckit MA, Soyka M, Treutlein J, Witt S, Wodarz N, Zill P, Adkins DE, Boden JM, Boomsma DI, Bierut LJ, Brown SA, Bucholz KK, Cichon S, Costello EJ, de Wit H, Diazgranados N, Dick DM, Eriksson JG, Farrer LA, Foroud TM, Gillespie NA, Goate AM, Goldman D, Grucza RA, Hancock DB, Harris KM, Heath AC, Hesselbrock V, Hewitt JK, Hopfer CJ, Horwood J, Iacono W, Johnson EO, Kaprio JA, Karpyak VM, Kendler KS, Kranzler HR, Krauter K, Lichtenstein P, Lind PA, McGue M, MacKillop J, Madden PAF, Maes HH, Magnusson P, Martin NG, Medland SE, Montgomery GW, Nelson EC, Nöthen MM, Palmer AA, Pedersen NL, Penninx BWJH, Porjesz B, Rice JP, Rietschel M, Riley BP, Rose R, Rujescu D, Shen PH, Silberg J, Stallings MC, Tarter RE, Vanyukov MM, Vrieze S, Wall TL, Whitfield JB, Zhao H, Neale BM, Gelernter J, Edenberg HJ, Agrawal A.

Nat Neurosci. 2018 Dec;21(12):1656-1669. doi: 10.1038/s41593-018-0275-1. Epub 2018 Nov 26.

10.

Insights from molecular signature of in vivo cardiac c-Kit(+) cells following cardiac injury and β-catenin inhibition.

Hodgkinson CP, Gomez JA, Baksh SS, Payne A, Schmeckpeper J, Pratt RE, Dzau VJ.

J Mol Cell Cardiol. 2018 Oct;123:64-74. doi: 10.1016/j.yjmcc.2018.08.024. Epub 2018 Aug 29.

11.

Host-parasite interaction associated with major mental illness.

Kano SI, Hodgkinson CA, Jones-Brando L, Eastwood S, Ishizuka K, Niwa M, Choi EY, Chang DJ, Chen Y, Velivela SD, Leister F, Wood J, Chowdari K, Ducci F, Caycedo DA, Heinz E, Newman ER, Cascella N, Mortensen PB, Zandi PP, Dickerson F, Nimgaonkar V, Goldman D, Harrison PJ, Yolken RH, Sawa A.

Mol Psychiatry. 2018 Aug 20. doi: 10.1038/s41380-018-0217-z. [Epub ahead of print]

12.

The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer.

Lallo A, Frese KK, Morrow CJ, Sloane R, Gulati S, Schenk MW, Trapani F, Simms N, Galvin M, Brown S, Hodgkinson CL, Priest L, Hughes A, Lai Z, Cadogan E, Khandelwal G, Simpson KL, Miller C, Blackhall F, O'Connor MJ, Dive C.

Clin Cancer Res. 2018 Oct 15;24(20):5153-5164. doi: 10.1158/1078-0432.CCR-17-2805. Epub 2018 Jun 25.

13.

Cardiomyocyte Maturation Requires TLR3 Activated Nuclear Factor Kappa B.

Hodgkinson CP, Pratt RE, Kirste I, Dal-Pra S, Cooke JP, Dzau VJ.

Stem Cells. 2018 Aug;36(8):1198-1209. doi: 10.1002/stem.2833. Epub 2018 Apr 22.

14.

Effects on gene expression and behavior of untagged short tandem repeats: the case of arginine vasopressin receptor 1a (AVPR1a) and externalizing behaviors.

Landefeld CC, Hodgkinson CA, Spagnolo PA, Marietta CA, Shen PH, Sun H, Zhou Z, Lipska BK, Goldman D.

Transl Psychiatry. 2018 Mar 27;8(1):72. doi: 10.1038/s41398-018-0120-z.

15.

The proximity-labeling technique BioID identifies sorting nexin 6 as a member of the insulin-like growth factor 1 (IGF1)-IGF1 receptor pathway.

Bareja A, Hodgkinson CP, Soderblom E, Waitt G, Dzau VJ.

J Biol Chem. 2018 Apr 27;293(17):6449-6459. doi: 10.1074/jbc.RA118.002406. Epub 2018 Mar 12.

16.

Understanding the mechanism of bias signaling of the insulin-like growth factor 1 receptor: Effects of LL37 and HASF.

Bareja A, Patel S, Hodgkinson CP, Payne A, Dzau VJ.

Cell Signal. 2018 Jun;46:113-119. doi: 10.1016/j.cellsig.2018.02.013. Epub 2018 Feb 28.

PMID:
29499305
17.

Association of genetic ancestry with striatal dopamine D2/D3 receptor availability.

Wiers CE, Towb PC, Hodgkinson CA, Shen PH, Freeman C, Miller G, Lindgren E, Shokri-Kojori E, Demiral ŞB, Kim SW, Tomasi D, Sun H, Wang GJ, Goldman D, Volkow ND.

Mol Psychiatry. 2018 Aug;23(8):1711-1716. doi: 10.1038/mp.2017.208. Epub 2017 Nov 7.

18.

Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder.

Lohoff FW, Sorcher JL, Rosen AD, Mauro KL, Fanelli RR, Momenan R, Hodgkinson CA, Vendruscolo LF, Koob GF, Schwandt M, George DT, Jones IS, Holmes A, Zhou Z, Xu MJ, Gao B, Sun H, Phillips MJ, Muench C, Kaminsky ZA.

Mol Psychiatry. 2018 Sep;23(9):1900-1910. doi: 10.1038/mp.2017.168. Epub 2017 Aug 29.

19.

Dimensional Traits of Schizotypy Associated With Glycine Receptor GLRA1 Polymorphism: An Exploratory Candidate-Gene Association Study.

Vora AK, Fisher AM, New AS, Hazlett EA, McNamara M, Yuan Q, Zhou Z, Hodgkinson C, Goldman D, Siever LJ, Roussos P, Perez-Rodriguez MM.

J Pers Disord. 2018 Jun;32(3):421-432. doi: 10.1521/pedi_2017_31_303. Epub 2017 Jul 31.

20.

Heightened amygdala responsiveness in s-carriers of 5-HTTLPR genetic polymorphism reflects enhanced cortical rather than subcortical inputs: An MEG study.

Luo Q, Holroyd T, Mitchell D, Yu H, Cheng X, Hodgkinson C, Chen G, McCaffrey D, Goldman D, Blair RJ.

Hum Brain Mapp. 2017 Sep;38(9):4313-4321. doi: 10.1002/hbm.23616. Epub 2017 Jun 5.

21.

Extracellular dopamine, acetylcholine, and activation of dopamine D1 and D2 receptors after selective breeding for cocaine self-administration in rats.

Xu H, Das S, Sturgill M, Hodgkinson C, Yuan Q, Goldman D, Grasing K.

Psychopharmacology (Berl). 2017 Aug;234(16):2475-2487. doi: 10.1007/s00213-017-4640-7. Epub 2017 May 26.

22.

The Leu72Met Polymorphism of the Prepro-ghrelin Gene is Associated With Alcohol Consumption and Subjective Responses to Alcohol: Preliminary Findings.

Suchankova P, Yan J, Schwandt ML, Stangl BL, Jerlhag E, Engel JA, Hodgkinson CA, Ramchandani VA, Leggio L.

Alcohol Alcohol. 2017 Jul 1;52(4):425-430. doi: 10.1093/alcalc/agx021.

23.

Joint Impact of Early Life Adversity and COMT Val158Met (rs4680) Genotypes on the Adult Cortisol Response to Psychological Stress.

Lovallo WR, Enoch MA, Sorocco KH, Vincent AS, Acheson A, Cohoon AJ, Hodgkinson CA, Goldman D.

Psychosom Med. 2017 Jul/Aug;79(6):631-637. doi: 10.1097/PSY.0000000000000481.

24.

New Repeat Polymorphism in the AKT1 Gene Predicts Striatal Dopamine D2/D3 Receptor Availability and Stimulant-Induced Dopamine Release in the Healthy Human Brain.

Shumay E, Wiers CE, Shokri-Kojori E, Kim SW, Hodgkinson CA, Sun H, Tomasi D, Wong CT, Weinberger DR, Wang GJ, Fowler JS, Volkow ND.

J Neurosci. 2017 May 10;37(19):4982-4991. doi: 10.1523/JNEUROSCI.3155-16.2017. Epub 2017 Apr 17. Erratum in: J Neurosci. 2017 Aug 16;37(33):8043.

25.

Brain-derived neurotrophic factor Val66Met genotype modulates amygdala habituation.

Perez-Rodriguez MM, New AS, Goldstein KE, Rosell D, Yuan Q, Zhou Z, Hodgkinson C, Goldman D, Siever LJ, Hazlett EA.

Psychiatry Res Neuroimaging. 2017 May 30;263:85-92. doi: 10.1016/j.pscychresns.2017.03.008. Epub 2017 Mar 24.

26.

Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo.

Dal-Pra S, Hodgkinson CP, Mirotsou M, Kirste I, Dzau VJ.

Circ Res. 2017 Apr 28;120(9):1403-1413. doi: 10.1161/CIRCRESAHA.116.308741. Epub 2017 Feb 16.

27.

Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant.

Sloan ME, Gowin JL, Yan J, Schwandt ML, Spagnolo PA, Sun H, Hodgkinson CA, Goldman D, Ramchandani VA.

Addict Biol. 2018 Jan;23(1):474-484. doi: 10.1111/adb.12491. Epub 2017 Feb 1.

28.

HASF (C3orf58) is a novel ligand of the insulin-like growth factor 1 receptor.

Bareja A, Hodgkinson CP, Payne AJ, Pratt RE, Dzau VJ.

Biochem J. 2017 Feb 20;474(5):771-780. doi: 10.1042/BCJ20160976.

PMID:
28096202
29.

Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs.

Li Y, Dal-Pra S, Mirotsou M, Jayawardena TM, Hodgkinson CP, Bursac N, Dzau VJ.

Sci Rep. 2016 Dec 12;6:38815. doi: 10.1038/srep38815.

30.

Hepatic, lipid and genetic factors associated with obesity: crosstalk with alcohol dependence?

Goodyear K, Lee MR, Schwandt ML, Hodgkinson CA, Leggio L.

World J Biol Psychiatry. 2017 Mar;18(2):120-128. doi: 10.1080/15622975.2016.1249952. Epub 2016 Dec 1.

31.

Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer.

Carter L, Rothwell DG, Mesquita B, Smowton C, Leong HS, Fernandez-Gutierrez F, Li Y, Burt DJ, Antonello J, Morrow CJ, Hodgkinson CL, Morris K, Priest L, Carter M, Miller C, Hughes A, Blackhall F, Dive C, Brady G.

Nat Med. 2017 Jan;23(1):114-119. doi: 10.1038/nm.4239. Epub 2016 Nov 21.

PMID:
27869802
32.

Defining the role of corticotropin releasing factor binding protein in alcohol consumption.

Haass-Koffler CL, Henry AT, Melkus G, Simms JA, Naemmuddin M, Nielsen CK, Lasek AW, Magill M, Schwandt ML, Momenan R, Hodgkinson CA, Bartlett SE, Swift RM, Bonci A, Leggio L.

Transl Psychiatry. 2016 Nov 15;6(11):e953. doi: 10.1038/tp.2016.208.

33.

Genome-wide association study in essential tremor identifies three new loci.

Müller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, Soto-Ortolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Dion PA, Wurster I, Shulman JM, Srulijes K, Haubenberger D, Pastor P, Vilariño-Güell C, Postuma RB, Bernard G, Ladwig KH, Dupré N, Jankovic J, Strauch K, Panisset M, Winkelmann J, Testa CM, Reischl E, Zeuner KE, Ross OA, Arzberger T, Chouinard S, Deuschl G, Louis ED, Kuhlenbäumer G, Rouleau GA.

Brain. 2016 Dec;139(Pt 12):3163-3169. Epub 2016 Oct 20.

34.

The abundance of cis-acting loci leading to differential allele expression in F1 mice and their relationship to loci harboring genes affecting complex traits.

Yeo S, Hodgkinson CA, Zhou Z, Jung J, Leung M, Yuan Q, Goldman D.

BMC Genomics. 2016 Aug 11;17(1):620. doi: 10.1186/s12864-016-2922-9.

35.

A Spontaneous Missense Mutation in Branched Chain Keto Acid Dehydrogenase Kinase in the Rat Affects Both the Central and Peripheral Nervous Systems.

Zigler JS Jr, Hodgkinson CA, Wright M, Klise A, Sundin O, Broman KW, Hejtmancik F, Huang H, Patek B, Sergeev Y, Hose S, Brayton C, Xaiodong J, Vasquez D, Maragakis N, Mori S, Goldman D, Hoke A, Sinha D.

PLoS One. 2016 Jul 29;11(7):e0160447. doi: 10.1371/journal.pone.0160447. eCollection 2016.

36.

Association of Superoxide Dismutase 2 (SOD2) Genotype with Gray Matter Volume Shrinkage in Chronic Alcohol Users: Replication and Further Evaluation of an Addiction Gene Panel.

Gitik M, Srivastava V, Hodgkinson CA, Shen PH, Goldman D, Meyerhoff DJ.

Int J Neuropsychopharmacol. 2016 Sep 21;19(9). pii: pyw033. doi: 10.1093/ijnp/pyw033. Print 2016 Sep.

37.

Inhibition of PI3K/BMX Cell Survival Pathway Sensitizes to BH3 Mimetics in SCLC.

Potter DS, Galvin M, Brown S, Lallo A, Hodgkinson CL, Blackhall F, Morrow CJ, Dive C.

Mol Cancer Ther. 2016 Jun;15(6):1248-60. doi: 10.1158/1535-7163.MCT-15-0885. Epub 2016 Mar 29.

38.

A Prospective Cohort Study of Influences on Externalizing Behaviors Across Childhood: Results From a Nurse Home Visiting Randomized Controlled Trial.

Enoch MA, Kitzman H, Smith JA, Anson E, Hodgkinson CA, Goldman D, Olds DL.

J Am Acad Child Adolesc Psychiatry. 2016 May;55(5):376-82. doi: 10.1016/j.jaac.2016.02.007. Epub 2016 Mar 2.

39.

Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.

Morrow CJ, Trapani F, Metcalf RL, Bertolini G, Hodgkinson CL, Khandelwal G, Kelly P, Galvin M, Carter L, Simpson KL, Williamson S, Wirth C, Simms N, Frankliln L, Frese KK, Rothwell DG, Nonaka D, Miller CJ, Brady G, Blackhall FH, Dive C.

Ann Oncol. 2016 Jun;27(6):1155-60. doi: 10.1093/annonc/mdw122. Epub 2016 Mar 24.

40.

Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog.

Wang X, Hodgkinson CP, Lu K, Payne AJ, Pratt RE, Dzau VJ.

Sci Rep. 2016 Mar 15;6:23017. doi: 10.1038/srep23017.

41.

Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology.

Hodgkinson CP, Bareja A, Gomez JA, Dzau VJ.

Circ Res. 2016 Jan 8;118(1):95-107. doi: 10.1161/CIRCRESAHA.115.305373. Review.

42.

Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.

Testoni E, Stephenson NL, Torres-Ayuso P, Marusiak AA, Trotter EW, Hudson A, Hodgkinson CL, Morrow CJ, Dive C, Brognard J.

EMBO Mol Med. 2016 Feb 1;8(2):105-16. doi: 10.15252/emmm.201505456.

43.

GABBR1 and SLC6A1, Two Genes Involved in Modulation of GABA Synaptic Transmission, Influence Risk for Alcoholism: Results from Three Ethnically Diverse Populations.

Enoch MA, Hodgkinson CA, Shen PH, Gorodetsky E, Marietta CA, Roy A, Goldman D.

Alcohol Clin Exp Res. 2016 Jan;40(1):93-101. doi: 10.1111/acer.12929.

44.

Development of a circulating miRNA assay to monitor tumor burden: From mouse to man.

Greystoke A, Ayub M, Rothwell DG, Morris D, Burt D, Hodgkinson CL, Morrow CJ, Smith N, Aung K, Valle J, Carter L, Blackhall F, Dive C, Brady G.

Mol Oncol. 2016 Feb;10(2):282-91. doi: 10.1016/j.molonc.2015.10.004. Epub 2015 Oct 28.

45.

Early-Life Adversity Interacts with FKBP5 Genotypes: Altered Working Memory and Cardiac Stress Reactivity in the Oklahoma Family Health Patterns Project.

Lovallo WR, Enoch MA, Acheson A, Cohoon AJ, Sorocco KH, Hodgkinson CA, Vincent AS, Goldman D.

Neuropsychopharmacology. 2016 Jun;41(7):1724-32. doi: 10.1038/npp.2015.347. Epub 2015 Dec 3.

46.

Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.

Schwantes-An TH, Zhang J, Chen LS, Hartz SM, Culverhouse RC, Chen X, Coon H, Frank J, Kamens HM, Konte B, Kovanen L, Latvala A, Legrand LN, Maher BS, Melroy WE, Nelson EC, Reid MW, Robinson JD, Shen PH, Yang BZ, Andrews JA, Aveyard P, Beltcheva O, Brown SA, Cannon DS, Cichon S, Corley RP, Dahmen N, Degenhardt L, Foroud T, Gaebel W, Giegling I, Glatt SJ, Grucza RA, Hardin J, Hartmann AM, Heath AC, Herms S, Hodgkinson CA, Hoffmann P, Hops H, Huizinga D, Ising M, Johnson EO, Johnstone E, Kaneva RP, Kendler KS, Kiefer F, Kranzler HR, Krauter KS, Levran O, Lucae S, Lynskey MT, Maier W, Mann K, Martin NG, Mattheisen M, Montgomery GW, Müller-Myhsok B, Murphy MF, Neale MC, Nikolov MA, Nishita D, Nöthen MM, Nurnberger J, Partonen T, Pergadia ML, Reynolds M, Ridinger M, Rose RJ, Rouvinen-Lagerström N, Scherbaum N, Schmäl C, Soyka M, Stallings MC, Steffens M, Treutlein J, Tsuang M, Wall TL, Wodarz N, Yuferov V, Zill P, Bergen AW, Chen J, Cinciripini PM, Edenberg HJ, Ehringer MA, Ferrell RE, Gelernter J, Goldman D, Hewitt JK, Hopfer CJ, Iacono WG, Kaprio J, Kreek MJ, Kremensky IM, Madden PA, McGue M, Munafò MR, Philibert RA, Rietschel M, Roy A, Rujescu D, Saarikoski ST, Swan GE, Todorov AA, Vanyukov MM, Weiss RB, Bierut LJ, Saccone NL.

Behav Genet. 2016 Mar;46(2):151-69. doi: 10.1007/s10519-015-9737-3. Epub 2015 Sep 21.

47.

Resting-state functional connectivity and presynaptic monoamine signaling in Alcohol Dependence.

Zhu X, Dutta N, Helton SG, Schwandt M, Yan J, Hodgkinson CA, Cortes CR, Kerich M, Hall S, Sun H, Phillips M, Momenan R, Lohoff FW.

Hum Brain Mapp. 2015 Dec;36(12):4808-18. doi: 10.1002/hbm.22951. Epub 2015 Sep 14.

48.

Effect of Functionally Significant Deiodinase Single Nucleotide Polymorphisms on Drinking Behavior in Alcohol Dependence: An Exploratory Investigation.

Lee MR, Schwandt ML, Bollinger JW, Dias AA, Oot EN, Goldman D, Hodgkinson CA, Leggio L.

Alcohol Clin Exp Res. 2015 Sep;39(9):1665-70. doi: 10.1111/acer.12814. Epub 2015 Jul 24.

49.

The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence.

Suchankova P, Yan J, Schwandt ML, Stangl BL, Caparelli EC, Momenan R, Jerlhag E, Engel JA, Hodgkinson CA, Egli M, Lopez MF, Becker HC, Goldman D, Heilig M, Ramchandani VA, Leggio L.

Transl Psychiatry. 2015 Jun 16;5:e583. doi: 10.1038/tp.2015.68.

50.

A genome-wide association study of suicidal behavior.

Galfalvy H, Haghighi F, Hodgkinson C, Goldman D, Oquendo MA, Burke A, Huang YY, Giegling I, Rujescu D, Bureau A, Turecki G, Mann JJ.

Am J Med Genet B Neuropsychiatr Genet. 2015 Oct;168(7):557-63. doi: 10.1002/ajmg.b.32330. Epub 2015 Jun 16.

PMID:
26079190

Supplemental Content

Loading ...
Support Center